Teplizumab: the FDA’s decision still gives hope for a type 1 diabetes immunotherapy
"Although today’s news wasn’t exactly what we hoped for, it is not the end for teplizumab"
Read Conor's story
| 06 July 2021
Steering the course of research: Putting women with diabetes in the driving seat
"The project put the experience of people affected by diabetes at the forefront. "
Read Caroline's story
| 28 June 2021
CGM gave me my child
"I can't imagine life without my daughter. I thank the NHS and CGM for the gift of her."
Read Sophia's story
| 23 June 2021
Sharing the load through tech – one family’s experience of the artificial pancreas on the NHS
"He’s a very happy, healthy boy and that’s the main thing."
Read Sara and Tim's story
| 17 June 2021
From glass syringes to the artificial pancreas app: Finding the tech that works through 40 years of diabetes
"Within days of starting the CamAPS FX system I began to notice improvements in my diabetes"
Read Les's story
| 16 June 2021
Professor Roman Hovorka: how a mathematician built the artificial pancreas for type 1 diabetes
"I realised the extent of the challenges type 1 diabetes poses"
Read Roman's story
| 03 June 2021
Breaking barriers in type 1 diabetes research
"What if we could say in another 25 years that we had eradicated type 1 in childhood?"
Read Colin's story
| 26 May 2021
How our immunotherapy research aims to cure type 1 diabetes
"We’re confident that we'll create a world without type 1 diabetes."
Read Conor's story
| 19 May 2021
Taking on the challenge: Jonty Brown on staying sporty with type 1 diabetes
"I have never let type 1 diabetes stop me taking on new challenges."
Read Jonty's story
| 22 April 2021